Labshake search
Citations for BioLegend :
3351 - 3400 of 10000+ citations since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2024Quote: ... CD25 (1:250; 135019 Biolegend), and CD127 (1:250 ...
-
bioRxiv - Cancer Biology 2024Quote: (BioLegend cat. 352911), BV605-PDGFRB (BD Biosciences cat ...
-
bioRxiv - Cell Biology 2024Quote: ... and CD90-PE Clone: 5E10 (Biolegend, 1:33)) at 4°C for 30 minutes ...
-
bioRxiv - Cell Biology 2024Quote: ... Clone: 5E10 (Biolegend, 1:33)) as previously described ...
-
bioRxiv - Cancer Biology 2024Quote: Neutrophils were isolated from the blood of MMTV-PyMT tumour bearing mice using MojoSort Mouse Neutrophil Isolation Kit (Biolegend), with neutrophil retention via negative selection strategy ...
-
bioRxiv - Cancer Biology 2024Quote: ... together with Brefeldin A (BioLegend), single-cell suspensions were incubated for Fc block (BioLegend ...
-
bioRxiv - Cancer Biology 2024Quote: MDA-MB-436 cells were resuspended in cell staining buffer (PBS + 5 mM EDTA + 1% BSA + 1.6 mM NaOH + 0.01% sodium azide) and incubated in 1:100 diluted Zombie Violet viability dye (Biolegend, 423113) for 5 minutes on ice ...
-
bioRxiv - Cancer Biology 2024Quote: ... and dead cells were identified with Zombie Green or Zombie NIR viability dye (BioLegend). Intracellular staining was performed after fixation and permeabilization with staining kit (00-5523-00 ...
-
bioRxiv - Cancer Biology 2024Quote: ... T cells were isolated from the spleen and lymph nodes of FVB/N mice using the MojoSort Mouse CD8 T cell isolation kit (BioLegend) as per the manufacturer’s protocol for negative selection strategy ...
-
bioRxiv - Cancer Biology 2024Quote: ... single-cell suspensions were incubated for Fc block (BioLegend) in 0.5% BSA/PBS buffer for 20 min on ice ...
-
bioRxiv - Cancer Biology 2024Quote: ... and engraftment was assessed regularly by flow cytometric detection of human CD45+ cell percentage (BioLegend, #304011) in peripheral blood starting four weeks post injection (Vogt et al ...
-
bioRxiv - Cancer Biology 2024Quote: Fluorescence-conjugated antibodies used in FACS were purchased from BioLegend (San Diego, CA). Antibodies in the myeloid and NK cell panel were ...
-
bioRxiv - Cancer Biology 2024Quote: ... was used for dead cell exclusion and FcγR III/II receptors were blocked with FcX TruStain (BioLegend) using the manufacturer’s instructions ...
-
bioRxiv - Bioengineering 2024Quote: ... CD11b (M1/70, BV510, BioLegend), CD11c (N418 ...
-
bioRxiv - Cancer Biology 2024Quote: ... anti- mouse NK1.1 (Cat. #108736, Biolegend), anti-mouse B220 (Cat ...
-
bioRxiv - Cancer Biology 2024Quote: ... IL-6(Cat. #431301, Biolegend) and glucose(Cat ...
-
bioRxiv - Cancer Biology 2024Quote: ... anti-mouse CD3 (Cat. #100355, Biolegend), anti-mouse CD4 (Cat ...
-
bioRxiv - Biophysics 2024Quote: ... Alexa Fluor 647 anti-human CD63 antibody (353016) was obtained from BioLegend. Alexa Fluor 488-labeled mouse anti-human CD81 antibody (MCA1847A488 ...
-
bioRxiv - Cancer Biology 2024Quote: ... and incubated for 30 min at 4°C with 1 µL of PE anti-human FasL antibody (clone NOK-1) from BioLegend. Nonspecific background signals were measured by incubating cells with the appropriate isotype-matched antibody ...
-
bioRxiv - Cancer Biology 2024Quote: ... PerCP/Cy5.5-conjugated anti CD25 (Clone BC96, BioLegend, Cat. 302626), and FITC-conjugated CD69 (Clone FN50 ...
-
bioRxiv - Cancer Biology 2024Quote: ... or Zombie Violet viability dye (Biolegend, 423113) for 5 minutes on ice ...
-
bioRxiv - Cancer Biology 2024Quote: ... and FITC-conjugated CD69 (Clone FN50, BioLegend, Cat. 310904) antibodies for 30 min on ice ...
-
bioRxiv - Cancer Biology 2024Quote: ... and anti-Ly-6G(Gr1)-AF700 (BioLegend 127622). Propidium Iodide was used to exclude dead cells ...
-
bioRxiv - Cancer Biology 2024Quote: ... anti-CD8-AF700 (BioLegend 100730), and anti-PD-1(CD279)-PE/Cy7 (BioLegend 135216) ...
-
bioRxiv - Cancer Biology 2024Quote: ... anti-CD3-PB (BioLegend 100214), anti-CD4-APC (BioLegend 100412) ...
-
bioRxiv - Cancer Biology 2024Quote: ... anti-CD19-FITC (BioLegend 115506), anti-B220-FITC (BioLegend 103206) ...
-
bioRxiv - Cancer Biology 2024Quote: ... anti-NK1.1-FITC (BioLegend 108706), anti-CD3-PB (BioLegend 100214) ...
-
bioRxiv - Cancer Biology 2024Quote: Non-specific binding was blocked by incubating cells with TruStain FcX (anti-mouse Cd16/32, BioLegend) for 5-10 minutes ...
-
bioRxiv - Cancer Biology 2024Quote: ... Human CD33 PE (Biolegend Inc 366608), Human Ki-67 BV421 (Biolegend Inc 350506) ...
-
bioRxiv - Cancer Biology 2024Quote: ... Human HLA-DR Alexa Fluor 488 (Biolegend Inc 307620), Human CD16 PE/Dazzletrade 594 (Biolegend Inc 302054) ...
-
bioRxiv - Cell Biology 2024Quote: ... and anti-XBP1s antibody (Biolegend 658802), except that the MEFs were directly fixed with 1% formaldehyde before subject to nuclei isolation and chromatin immunoprecipitation ...
-
bioRxiv - Cell Biology 2024Quote: ... incubated overnight at 4°C with primary antibodies (anti-HA, 1:1000, BioLegend, #901502 ...
-
bioRxiv - Cancer Biology 2024Quote: ... OS cells were seeded into 24-well plates and incubated for 72 hours in basal medium alone or basal media supplemented with 10 ng/ml of either recombinant IL1α or IL1β (Biolegend, 570004 and 579404). Following incubation ...
-
bioRxiv - Cancer Biology 2024Quote: ... Stimulated PBMCs were maintained in RPMI-1640 supplemented media with 100 ng/ml CD3 and 10 ng/ml recombinant human IL-2 (Biolegend, 589104).
-
bioRxiv - Cell Biology 2024Quote: ... Clone: 581 (Biolegend, 1:50), and CD90-PE ...
-
bioRxiv - Cell Biology 2024Quote: ... Clone: HI100 (Biolegend, 1:100), CD34-FITC ...
-
bioRxiv - Cell Biology 2024Quote: ... cells were stained with cell surface marker antibodies (CD38-V450 Clone: HIT2 (Biolegend, 1:100), CD45RA-PE-Cy7 ...
-
bioRxiv - Cancer Biology 2024Quote: ... cells were pretreated with 100 U/mL IFN-γ for 24h and stained with 1:1000 H2kb-SIINFEKL Ab (BioLegend,Clone:25-D1.16). GFP-expressing cell lines were used for GFP compensation ...
-
bioRxiv - Cancer Biology 2024Quote: ... F4/80 (clone BM8, Biolegend), MHC II (clone M5/114.15.2 ...
-
bioRxiv - Cancer Biology 2024Quote: ... anti-mouse Ly6c-PerCP/Cyanine5.5 (1:100, 128012, Biolegend), and anti-mouse/human CD11b-PE (1:200 ...
-
bioRxiv - Cancer Biology 2024Quote: ... and anti-mouse/human CD11b-PE (1:200, 101207, Biolegend). The following isotype antibodies were diluted in FACS Buffer to be used in the MDSC surface staining panel ...
-
bioRxiv - Cancer Biology 2024Quote: ... The following antibodies were used: anti-CD45-BV605 (BioLegend, 103139, clone 30-F11, 1:100), anti-CD11b-PE-Cy7 (Biolegend ...
-
bioRxiv - Cancer Biology 2024Quote: ... CD8a (clone 53-6.7, Biolegend), CD11b (clone M1/70 ...
-
bioRxiv - Cancer Biology 2024Quote: ... CD11b (clone M1/70, Biolegend), CD11c (clone N418 ...
-
bioRxiv - Cancer Biology 2024Quote: ... Ly6C (clone HK1.4, Biolegend), Ly6G (clone 1A8 ...
-
bioRxiv - Cancer Biology 2024Quote: ... anti-mouse Ly6g-FITC (1:300, 127605, Biolegend), anti-mouse Ly6c-PerCP/Cyanine5.5 (1:100 ...
-
bioRxiv - Cancer Biology 2024Quote: ... anti-Ly6C-PE (Biolegend, 1280008, clone HK1.4, 1:200), anti-CCR2-APC (Biolegend ...
-
bioRxiv - Cancer Biology 2024Quote: ... CD45 (clone 30-F11, Biolegend), CD8a (clone 53-6.7 ...
-
bioRxiv - Cancer Biology 2024Quote: ... and TCRb (clone H57-597, Biolegend) were used for validation of marker staining.
-
bioRxiv - Cancer Biology 2024Quote: ... anti-CD11b-PE-Cy7 (Biolegend, 101215, clone M1/70, 1:100), anti-CD3-PerCP-eFluor 710 (Thermo Fischer ...